Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Yum China Holdings Inc (YUMC) Price & Performance

Novartis AGTrade
Yum China Holdings IncTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Yum China Holdings Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Yum China Holdings Inc trades at $43.91 (market cap $15.09B). The key difference: Novartis AG is far larger — about 19.2× Yum China Holdings Inc's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.

NVSYUMC
Market Cap
$290.25B$15.09B
Sector
HealthConsumer Cyclical
52-Week High
$168.62$57.95
52-Week Low
$113.50$40.18
Enterprise Value
$330.27B$15.98B
Dividend Yield
3.17%2.64%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Yum China Holdings Inc

With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.

Read more on YUMC